Expression of CCL19 (which expressed a 2.6-fold-change in MCTVT) and C5AR1 (which expressed a 2.28-fold-change in MCTVT) is highly associated with the advanced tumour stage and promotes cell proliferation in several cancers, leading to poor patient outcomes [29, 30]. This evidence concerns the gene CCL19 and neoplasm.